Our next era
Meet the new Novartis as we begin our next phase as an innovative medicines company.
How can we improve equity in healthcare?
Beacon of Hope is a partnership to co-create effective, measurable solutions for health equity in the US. Learn more about our recent event in Washington, DC, addressing the systemic nature of the disparities that exist in healthcare today.
Discover our medicines
Our innovative medicines address society’s greatest disease burdens and restore possibility for patients.
Explore our science
Discover how we unravel the mysteries of biology and develop new technologies to fight disease and change lives.
Learn about our impact
Creating a medicine is just the beginning of the journey. Discover how we embrace societal impact as a core business objective.
Latest news
Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions
Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH
Novartis upgrades mid-term sales growth guidance, showcases its differentiated innovative medicines strategy and robust pipeline at R&D Day
Welcome to where we thrive together
Working together. Learning together. Thriving together. Discover how you can join us in changing people's lives.